NR667- CEA FNP EXAM WITH FULL PACK
SOLUTIONS
1.A lpatient lcurrently lundergoing lconcurrent lchemotherapy/radiation
ltreat- lment lfor lglottic lsquamous lcell lcarcinoma lis ladmitted lto lthe lrehab
lunit lyou loversee lfor lmanagement lof lintractable lnausea, lvomiting, land
ldehydration. lAdmission lCBC lshowed lWBC l1.3, lHgb l7.5, lPLT l45, lANC l0.8.
lWhich lof lthe lfollowing lconditions lis lthis lpatient lat lrisk lfor?
A. Macrocytic lanemia ldue lto lB12 ldeficiency
B. Iron ldeficiency lanemia ldue lto lchronic lblood lloss
C. Microcytic lanemia ldue lto lchronic lkidney ldisease
D. Aplastic lanemia ldue lto lbone lmarrow lsuppression: lD
2.Your lpatient lpresents lto lthe lurgent lcare lclinic lwith la lswollen lexudative
lpharynx, lprofound lfatigue, land la lvery ltender lleft lupper lquadrant
labdomen. lWhat lis lthe lmost llikely ldiagnosis?
A. Strep lpharyngitis
B. Tonsillitis
1 l/
l135
,C. Epstein lBarr lvirus l(EBV)
D. Pancreatitis: lC
3.Which lof lthe lfollowing lbest lcharacterizes lpresbycusis lin lthe lolder ladult?
A. Bilateral llow-frequency lsensorineural lhearing lloss
B. Bilateral lhigh-frequency lsensorineural lhearing lloss
C. Unilateral lhigh-frequency lsensorineural lhearing lloss
D. Unilateral llow-frequency lsensorineural lhearing lloss: lB
4.A l35-year-old lwoman lpresents lwith lallergic lrhinitis, lexperiencing
lsignificant lnasal lcongestion, lsneezing, land litchy leyes. lShe lhas ltried lover-
the-counter lantihistamines lwith llimited lrelief. lWhat lis lthe lmost lappropriate
lnext lstep lin lmanagement?
A. Oral ldecongestants
B. Nasal lsaline lirrigation
C. Intranasal lcorticosteroids
D. Referral lto lan lallergist lfor limmunotherapy: lC
5.A lpatient lcurrently lundergoing lconcurrent lchemotherapy/radiation
ltreat- lment lfor lglottic lsquamous lcell lcarcinoma lis ladmitted lto lthe lrehab
lunit lyou loversee lfor lmanagement lof lintractable lnausea, lvomiting, land
ldehydration. lAdmission lCBC lshowed lWBC l1.3, lHgb l7.5, lPLT l45, lANC l0.8.
lWhich lof lthe lfollowing lconditions lis lthis lpatient lat lrisk lfor?
2 l/
l135
,A. Iron ldeficiency lanemia ldue lto lchronic lblood lloss
B. Microcytic lanemia ldue lto lchronic lkidney ldisease
C. Macrocytic lanemia ldue lto lB12 ldeficiency
D. Aplastic lanemia ldue lto lbone lmarrow lsuppression: lD
6.A l78 ly.o. lM lpatient lreports lchronic linfections, lbruising, lfatigue, lSOB, land
lfevers. lHe lhas la lhistory lof lrectal ladenocarcinoma land lcompleted
lconcurrent lchemotherapy/radiation learlier lthis lyear. lHis lCBC lshows lHgb l7.5,
lPLT l88, lWBC l1.2, lANC l0.8, land lperipheral lsmear lshows ldysplasia. lWhat
ladditional lwork-up lwould lyou lanticipate lfor lthis lpatient?
A. Colonoscopy land lfecal loccult lblood ltest
B. Bone lmarrow lbiopsy land lflow lcytometry
C. No ladditional lwork-up lis lrequired, lthese lare lexpected lsequela lof lhis
lonco- llogic ltreatment
D. Repeat lCBC/CMP/peripheral lsmear lin leight lweeks: lB
7.Progression lto lAcute lMyelogenous lLeukemia l(AML) lis la lrisk lfor
luntreated lor lpoorly lresponsive:
A. Pancytopenia
B. Aplastic lanemia
C. Macrocytic lanemia
D. Myelodysplastic lsyndrome: lD
8.Treatment lfor lsymptomatic laplastic lanemia lincludes lall lthe lfollowing
lex- lcept:
A. Bone lmarrow ltransplant
B. PRBC/Platelet/WBC ltransfusions
C. Prophylactic lantibiotics
D. Removal lof lbone lmarrow lstimulants: lD
9.A lpatient ldiagnosed lwith liron ldeficiency lanemia lrequires liron
lsupplemen- ltation. lWhich lof lthe lfollowing ltreatments lwould llikely lbe
lineffective?
A. Ferrous lsulfate l325 lmg lPO lBID lfor la l43 ly.o. lF ls/p lgastric lbypass l2 lyears lag
B. Iron lsucrose l200 lmg lIV linfusion lweekly lx l8 lweeks lin la l26 ly.o. lF lat l34
lweeks lof lpregnancy
C. Ferrous lsulfate l325 lmg lPO lTID lfor la l25 ly.o. lF lwith lmenorrhagia
D. Ferrous lsulfate l325 lmg lPO lBID lfor la l63 ly.o. lM lwith lulcerative lcolitis: lA
10.Which lof lthe lfollowing lis lnot la lcommon lmechanism lof lneutrophil
3 l/
l135
, l expen- lditure land lresultant lneutropenia?
4 l/
l135
SOLUTIONS
1.A lpatient lcurrently lundergoing lconcurrent lchemotherapy/radiation
ltreat- lment lfor lglottic lsquamous lcell lcarcinoma lis ladmitted lto lthe lrehab
lunit lyou loversee lfor lmanagement lof lintractable lnausea, lvomiting, land
ldehydration. lAdmission lCBC lshowed lWBC l1.3, lHgb l7.5, lPLT l45, lANC l0.8.
lWhich lof lthe lfollowing lconditions lis lthis lpatient lat lrisk lfor?
A. Macrocytic lanemia ldue lto lB12 ldeficiency
B. Iron ldeficiency lanemia ldue lto lchronic lblood lloss
C. Microcytic lanemia ldue lto lchronic lkidney ldisease
D. Aplastic lanemia ldue lto lbone lmarrow lsuppression: lD
2.Your lpatient lpresents lto lthe lurgent lcare lclinic lwith la lswollen lexudative
lpharynx, lprofound lfatigue, land la lvery ltender lleft lupper lquadrant
labdomen. lWhat lis lthe lmost llikely ldiagnosis?
A. Strep lpharyngitis
B. Tonsillitis
1 l/
l135
,C. Epstein lBarr lvirus l(EBV)
D. Pancreatitis: lC
3.Which lof lthe lfollowing lbest lcharacterizes lpresbycusis lin lthe lolder ladult?
A. Bilateral llow-frequency lsensorineural lhearing lloss
B. Bilateral lhigh-frequency lsensorineural lhearing lloss
C. Unilateral lhigh-frequency lsensorineural lhearing lloss
D. Unilateral llow-frequency lsensorineural lhearing lloss: lB
4.A l35-year-old lwoman lpresents lwith lallergic lrhinitis, lexperiencing
lsignificant lnasal lcongestion, lsneezing, land litchy leyes. lShe lhas ltried lover-
the-counter lantihistamines lwith llimited lrelief. lWhat lis lthe lmost lappropriate
lnext lstep lin lmanagement?
A. Oral ldecongestants
B. Nasal lsaline lirrigation
C. Intranasal lcorticosteroids
D. Referral lto lan lallergist lfor limmunotherapy: lC
5.A lpatient lcurrently lundergoing lconcurrent lchemotherapy/radiation
ltreat- lment lfor lglottic lsquamous lcell lcarcinoma lis ladmitted lto lthe lrehab
lunit lyou loversee lfor lmanagement lof lintractable lnausea, lvomiting, land
ldehydration. lAdmission lCBC lshowed lWBC l1.3, lHgb l7.5, lPLT l45, lANC l0.8.
lWhich lof lthe lfollowing lconditions lis lthis lpatient lat lrisk lfor?
2 l/
l135
,A. Iron ldeficiency lanemia ldue lto lchronic lblood lloss
B. Microcytic lanemia ldue lto lchronic lkidney ldisease
C. Macrocytic lanemia ldue lto lB12 ldeficiency
D. Aplastic lanemia ldue lto lbone lmarrow lsuppression: lD
6.A l78 ly.o. lM lpatient lreports lchronic linfections, lbruising, lfatigue, lSOB, land
lfevers. lHe lhas la lhistory lof lrectal ladenocarcinoma land lcompleted
lconcurrent lchemotherapy/radiation learlier lthis lyear. lHis lCBC lshows lHgb l7.5,
lPLT l88, lWBC l1.2, lANC l0.8, land lperipheral lsmear lshows ldysplasia. lWhat
ladditional lwork-up lwould lyou lanticipate lfor lthis lpatient?
A. Colonoscopy land lfecal loccult lblood ltest
B. Bone lmarrow lbiopsy land lflow lcytometry
C. No ladditional lwork-up lis lrequired, lthese lare lexpected lsequela lof lhis
lonco- llogic ltreatment
D. Repeat lCBC/CMP/peripheral lsmear lin leight lweeks: lB
7.Progression lto lAcute lMyelogenous lLeukemia l(AML) lis la lrisk lfor
luntreated lor lpoorly lresponsive:
A. Pancytopenia
B. Aplastic lanemia
C. Macrocytic lanemia
D. Myelodysplastic lsyndrome: lD
8.Treatment lfor lsymptomatic laplastic lanemia lincludes lall lthe lfollowing
lex- lcept:
A. Bone lmarrow ltransplant
B. PRBC/Platelet/WBC ltransfusions
C. Prophylactic lantibiotics
D. Removal lof lbone lmarrow lstimulants: lD
9.A lpatient ldiagnosed lwith liron ldeficiency lanemia lrequires liron
lsupplemen- ltation. lWhich lof lthe lfollowing ltreatments lwould llikely lbe
lineffective?
A. Ferrous lsulfate l325 lmg lPO lBID lfor la l43 ly.o. lF ls/p lgastric lbypass l2 lyears lag
B. Iron lsucrose l200 lmg lIV linfusion lweekly lx l8 lweeks lin la l26 ly.o. lF lat l34
lweeks lof lpregnancy
C. Ferrous lsulfate l325 lmg lPO lTID lfor la l25 ly.o. lF lwith lmenorrhagia
D. Ferrous lsulfate l325 lmg lPO lBID lfor la l63 ly.o. lM lwith lulcerative lcolitis: lA
10.Which lof lthe lfollowing lis lnot la lcommon lmechanism lof lneutrophil
3 l/
l135
, l expen- lditure land lresultant lneutropenia?
4 l/
l135
